The Wound Care Center at Harrington Joins Healogics to Raise Awareness for Diabetic Foot Ulcers
The Wound Care Center at Harrington, a member of the Healogics network, is participating in the Healogics National Diabetes Campaign from October 26 to October 30.
The Wound Care Center at Harrington offers advanced therapies to patients suffering from chronic wounds like diabetic foot ulcers. Program directors across the nation will dedicate the entire week to visiting local physician offices to provide education to help staff identify diabetic patients with or at risk of having ulcers of the lower extremity.
There are approximately 29.1 million people living with diabetes in the United States, and nearly 28 percent are undiagnosed. Of those, about 25 percent will develop a diabetic foot ulcer. Left untreated, these ulcers can impair quality of life and may lead to amputation. Early detection and intervention can help to mitigate the possibility of limb loss.
The Wound Care Center at Harrington recommends the following to help prevent diabetic foot ulcers:
· Annual foot examinations by a healthcare provider
· Daily self-inspections of the feet, or have a family member perform the inspection
· Regular care of the feet including cleaning toenails and taking care of corns and calluses
· Choose supportive, proper footwear (shoes and socks)
· Take steps to improve circulation such as eating healthier and exercising on a regular basis
To learn more about the Wound Care Center at Harrington, visit www.harringtonhospital.org.
Headquartered in Jacksonville, Fla., Healogics is the nation’s largest provider of advanced wound care services. Healogics and its affiliated companies manage nearly 800 Wound Care Centers® in the nation and saw nearly 300,000 patients in 2014 through a connected network of partner hospitals and Wound Care Centers, academic medical centers, and other post‐acute sites. Healogics utilizes an evidence‐based systematic approach to chronic wound healing to treat an underserved and growing patient population. A fund managed by Clayton, Dubilier & Rice, a private investment firm, is the majority shareholder of Healogics. For more information, please visit www.healogics.com.